Abstract The generation of genetically engineered mouse models (GEMMs), including knock-out (KO) and knock-in (KI) models, often requires genomic screening of many mouse ES cell (mESC) clones by Southern blot. The use of large targeting constructs facilitates the recombination of exogenous DNA in a specific genomic locus, but limits the detection of its correct genomic integration by standard PCR methods. Genomic Long Range PCR (LR-PCR), using primers adjacent to the homology arms, has been used as an alternative to radioactive-based Southern blot screenings. However, LR-PCRs are often difficult and render many false positive and false negative results. Here, we propose an alternative screening method based on the detection of a genetic modification at the mRNA level, which we successfully optimized in two mouse models. This screening method consists of a reverse-transcription PCR (RT-PCR) using primers that match exons flanking the targeting construct. The detection of the expected modification in this PCR product confirms the integration at the correct genomic location and shows that the mutant mRNA is expressed. This is a simple and sensitive strategy to screen locus-specific recombination of targeting constructs which can also be useful to screen KO and KI mutant mice or cell lines including those generated by CRISPR/Cas9.
Introduction
In the past thirty years, the use of genetically engineered mouse models (GEMMs) has become increasingly popular to study the physiological functions of genes, and the roles of these in diseases (Capecchi 2005) . GEMMs, including knock-out (KO) and knock-in (KI) models, are commonly generated by gene targeting strategies (Austin et al. 2004 ). Typically, this approach involves transduction of mESCs with targeting constructs that contain the desired modification and an antibiotic resistance cassette for selection. Importantly, the targeting construct will replace the endogenous gene by homologous recombination (Hall et al. 2009 ). Notably, the efficiency of this process is highly variable and does not ensure the integration of the targeting construct in the desired genomic locus. Therefore, from the antibiotic resistant mESC clones obtained, only a small percentage will have introduced the genetic modification at the targeted endogenous locus. The availability of efficient and specific methods to screen genetically modified mESC clones is therefore of utmost importance for the generation and use of GEMMs.
To this end, Southern blotting is the most commonly used method to date. This approach requires screening of hundreds of mESC clones to identify those that have recombined the targeting construct in the correct genomic location. While highly specific, Southern blotting requires optimization for each probe and involves the use of radioactive isotopes, rendering this method less convenient. Furthermore, some genomic loci are very repetitive, complicating the design of the probe. Protocols using digoxigenin-labeled probes are also available (Solanas and Escrich 1997) ; however, their sensitivity and specificity are often a limiting factor. Alternatively, Long-Range PCR (LR-PCR)-based screening methods have been developed (Lay et al. 1998) in an attempt to avoid Southern blot methods. LR-PCR protocols rely on one primer annealing outside of the targeting construct and the other annealing to an internal exogenous sequence of the targeting construct. The homologous regions of the targeting constructs are usually long (4-7 kb), complicating the amplification of the desired fragments. Importantly, the optimization of the LR-PCR conditions is further complicated by the lack of an appropriate positive control that is only obtained if a correctly targeted mESC clone is found. The absence of a PCR product may therefore indicate that either the correct recombination event has not occurred or the PCR conditions were not optimal.
Here we propose a novel and simple protocol to identify mESC clones with a specific modification in the intended genomic location. Our method is based on the detection of the inserted modification at the mRNA level, which not only allows for detection of the modification but also ensures expression of the gene. We have successfully used this method to screen mESC clones transfected with two different targeting constructs. With this method we provide an efficient and reliable option that circumvents not only the complications of LR-PCR methods, but also handling of radioactivity that is necessary for Southern blotting.
Description of the RT-PCR screening strategy
To overcome the challenges of screening genetically modified mESC clones, we developed a RT-PCR screening strategy that is based on the detection of a KI modification at the mRNA level. First, cDNA is synthetized by retrotranscription of the mRNA, whereafter a portion of the expressed mRNA including the KI modification is amplified by a PCR reaction using at least one primer matching an exon outside the homology arms of the targeted locus (see Fig. 1 ). In contrast to LR-PCR, this RT-PCR can be designed to amplify a small PCR product. Importantly, a PCR product will be detected in all clones, both WT and mutant, while the genetic modification will only be detected if the targeting construct is integrated in the correct locus. Critically, as this method is based on mRNA, it is important to ensure that the targeted gene is expressed in mESC. We therefore recommend performing the RT-PCR detection in WT mESCs prior to commencing screenings of the genetically modified clones. Importantly, an advantage of performing the screening at the mRNA level is that it also confirms the expression of the modified gene.
From the RT-PCR product, the inserted genetic modification can be verified by Sanger sequencing (Fig. 1c) . As the targeting construct is most commonly only integrated in one of the alleles, the RT-PCR will give rise to molecules with both WT and KI sequences. Therefore, the sequencing chromatogram will show a mixture of the KI and WT sequences in positive mESC clones. Alternatively to Sanger sequencing, the genetic modification can be detected by allele-specific PCR (AS-PCR, see Fig. 1d ), a method commonly used for the detection of SNPs (Newton et al. 1989 ). In our screening method the AS-PCR is performed on the cDNA rather than on genomic DNA. The AS-PCR requires two PCR reactions to detect both alleles, using one common primer and one primer specific for either the WT or the KI sequences (Fig. 1d) . The detection of the KI modification, whether by DNA sequencing or AS-PCR, confirms the recombination of the targeting construct in the correct genomic location.
RT-PCR screening examples: Brca1 and Pich KI models
Pich K129A KI We applied and validated our strategy for screening mESC clones on two KI mouse models. In the first model described here, we generated a Pich KI strain with a single amino acid substitution in the ATPase catalytic domain of the PICH protein (K129A). To this end, the targeting construct containing a neomycin selection cassette was designed to introduce the modification AAG(Lys)[GCG(Ala) in exon 2 of the gene (Fig. 2a) . The homology arms of this construct spanned from 4.5 kb upstream to 4.0 kb downstream of exon 2. Electroporation of mESCs and selection of neomycin resistant clones was performed following standard protocols (Hall et al. 2009 ). Next, mESC clones with the desired integration of the construct were identified by sequencing and AS-PCR. First, cDNA was generated, followed by confirmation of integration of the construct in the desired locus by PCR (Fig. 2b) . Importantly, one of the primers was designed to match an exon outside of the targeting construct. As the Pich gene consists of two exons, to screen our KI mESC clones, one primer (Fw1 5 0 -GTCTCCTTTCCTGGGCTCTC-3 0 ) was located in exon 1, while the other was located downstream of the genetic modification in exon 2 (Rev1 5 0 -GATCA CAACGCCGTTCCTTT-3 0 ). DNA sequencing was performed using the same forward primer (Fw1) as for the amplification of the cDNA and heterozygous clones contained WT and KI nucleotide sequences (Fig. 2c) .
Additionally, AS-PCR was performed with two PCR reactions to confirm the presence of the WT and/ or modified Pich alleles. Both PCR reactions made use of a common forward primer (Fw2) in exon 1 in combination with a WT reverse primer (WT_Rev2 5 0 -GCAATGATCTGAACAGTCTT-3 0 ) or a KI specific reverse primer (KI_Rev2 5 0 -GCAATGATCTGAA CAGTCGC-3 0 ). Amplification of a PCR fragment only occurs in case of complete complementarity between the primer and its target sequence. Figure 2d shows an example of the Pich KI AS-PCR screening with two WT clones (lanes 1 and 2) and two positive heterozygous clones (lanes 3 and 4). (Fig. 3a) . To identify mESC clones with the desired recombination, cDNA was generated by RT-PCR from 86 neomycin resistant clones and subsequently used as template for AS-PCR. Next, two PCR reactions were performed using a common reverse primer located in exon 21 (Rev3 5 0 -TCATGGGT GAGCGATGGAAG-3 0 ) and specific forward primers located in exon 19, corresponding either to the WT or mutant sequence (WT_Fw3 5 0 -GGTTTCAGCAT GAATTTGAAGT-3 0 ; KI_Fw3 5 0 -GGTTTCAGCAT GAATTTGAAGC-3 0 ) (Fig. 3b) . Figure 3c shows an example of AS-PCR performed on Brca1 KI mESC. Note that in this case the AS-PCR was performed using the cDNA as template, whereas in the Pich KI screening an intermediate RT-PCR product was used as template. All clones showed an amplicon corresponding to the WT allele generated by the common Rev3 primer and the WT_Fw3 primer, while only one clone (number 2) produced an amplicon in the PCR reaction using the KI_Fw3 primer (Fig. 3c) . With this 
Advantages of the method and potential applications
While GEMMs are very useful tools for studying the functions of genes in physiological and pathological conditions, the screening of mESC clones for the correct integration of KI modifications is very time consuming. Standard methodologies require screening of many clones and Southern blot also involves handling of radioactivity. Our RT-PCR based screening method, described here, presents important advantages compared to Southern blot and LR-PCR protocols (1) it can replace Southern blot protocols and the use of radioactivity; (2) requires fewer cells compared to standard Southern blot protocols; (3) employs simple and reliable RT-PCR rather than LR-PCR methods; and (4) verifies expression of the modified gene in the selected mESC clone.
Prior to use of this method, two important facts need to be considered. First, in order to be detected by RT-PCR, the gene of interest must be expressed in mESCs. It is therefore critical to check the expression of the gene in the WT cells before proceeding with the actual screen. Second, the WT allele might be expressed at higher levels than the mutant allele, complicating the detection of the modification by sequencing of the RT-PCR band. In this case, it is possible to perform a specific AS-PCR that only amplifies the mutant allele, as described above (Fig. 1) .
Notably, the method we propose here can be applied for the screening of various types of genetic alterations. For instance, when generating conditional KO cells with LoxP sites surrounding an exon, a silent modification readily detectable by RT-PCR and sequencing can be introduced. This approach will greatly facilitate the screening of the clones. Furthermore, the silent modification(s) could also generate an extra restriction site that will facilitate the screening by RT-PCR followed by a restriction enzyme digestion. With the development of CRISPR-Cas9 genome editing technologies the generation and screening of GEMMs have been largely facilitated, yet our method offers a particular advantage to screen KI models generated with this approach. CRISPR KO mice are generated using Cas9 and guide RNAs (gRNAs) that specifically target the desired exon (Doudna and Charpentier 2014) . In addition, due to the high efficiency of CRISPR, KI modifications can also be introduced transducing Cas9, gRNA and a relatively short donor DNA by using different strategies (Inui et al. 2014) . Therefore, CRISPR technology facilitates the screening of positive clones at the DNA level by PCR and sequencing. However, random size deletions or insertions can occur in one of the sister chromosomes, and despite continuous improvement, offtarget genomic cleavage remains a considerable problem (Peng et al. 2016) . These by-products of CRISPR complicate the identification of modifications, and we believe our method, which is based on mRNA and RT-PCR, can facilitate the screening of mice generated by CRISPR technology.
In summary, we believe that this RT-PCR protocol is a very simple method that could replace current methodologies in order to screen for correct recombination of targeting constructs in mESCs and may have further applications in the current age of CRISPR-Cas9 genome editing.
